This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 11, 2013


















 



New hepatitis C diagnosis and treatment
By Rosemary Sparacio
Hepatitis C, a liver disease that results from infection with the hepatitis C virus, can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. The infection is often asymptomatic, but chronic infection can lead to liver diseases, which can become apparent after many years. Several new options are emerging that could change the way hepatitis C is treated.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  

Industry pulse: Which new treatment offers the most promise for hepatitis C?
ANSWER NOW


AREA & ASSOCIATION NEWS


RxVaccinate: Expand your immunization services
American Pharmacists Association
APhA is offering an opportunity for you to participate in a unique and innovative project designed to help you develop a plan for expanding your pneumococcal immunization services. The project is being funded by an unrestricted educational grant from Pfizer Medical Education group.

RxVaccinate is an educational project designed to provide pharmacists with the tools, resources and training needed to initiate community-specific strategies to increase pneumococcal vaccination rates.

Application to participate in the project is open to any pharmacy with at least one staff member who has been trained to deliver immunizations through APhA's nationally recognized certificate training program, Pharmacy-Based Immunization Delivery, and are authorized by state regulations to administer pneumococcal immunizations.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Arizona Health Emergency Response Coalitions
AzPA
Coyote Crisis Collaborative, a disaster preparedness support nonprofit funded primarily by ADHS, is looking for subject matter experts to offer guidance to the Health Emergency Response Coalition members to the central region of Arizona encompassing Maricopa, Pinal and Gila counties. The group is comprised of hospital emergency managers as well as others from allied health organizations, municipal representatives, EMS, etc. Topics include evacuation and the roles of allied health organizations in addressing mass casualty incidents. If you are interested in participating in this effort, please contact Kelly Ridgway, AzPA CEO.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Tucson infant survives whooping cough
Arizona Daily Star
Tiny Bryanna beats the odds, but her harrowing case illustrates whooping cough's grave danger for infants. The family shares the story to highlight grave risks of respiratory illness.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Just 2 weeks until the 2013 AzPA Annual Convention
AzPA
Just two weeks until the 2013 AzPA Annual Convention. Are you registered?

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Not an AzPA member? Join today
AzPA
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




PHARMACY UPDATES


Study: Flu shots at school boost vaccination rates
HealthDay News
Offering flu shots at elementary schools could reduce the number of flu cases and deaths among children, a new study suggests. Vaccination is the most effective way to protect children aged 6 months and older against seasonal flu, but vaccination rates among American children are low. Only about 40 percent of children received a 2012-2013 flu vaccine, according to the U.S. Centers for Disease Control and Prevention.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword CHILDHOOD VACCINATIONS.


2-dose emergency contraception ordered available OTC for all ages, for now
American Pharmacists Association
The U.S. Court of Appeals for the Second Circuit ordered June 5 that two-dose emergency contraceptive products must be made available OTC for all ages, at least until the court rules on an appeal by the Obama administration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug scares and pharmacy security create opportunity for small player
Minyanville
Recently, one of the raging news stories concerned the problems cropping up over compounded drugs, specifically steroids, and contaminated doses reaching and poisoning patients. With the Affordable Care Act now being phased into effect, the restrictions on pharmacies and doctor's ability to prescribe drugs will continue to become more onerous. The latest bit of legislation in the war on Oxycontin for example, is making its way through the Oklahoma government, where it will be flat-out illegal to write a prescription for hydrocodone.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Data mining EMRs can detect bad drug reactions
Medical News Today
Dr. Mei Liu, a computer scientist, has recently shown in a new study that electronic medical records can validate previously reported adverse drug reactions and report new ones. The study examined the use of retrospective medication orders and inpatient laboratory results documented in the medical records to identify adverse reactions. Twelve years of data from Vanderbilt University Medical Center were studied by Liu and a research team. The researchers correlated abnormal laboratory results with specific drug administrations by comparing the outcomes of a drug-exposed group and a matched unexposed group.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Opportunities and threats: Technology a double-edge sword for pharmacists (American Pharmacists Association)
US senator questions Medicare part D preferred pharmacy plans (NCPA)
Chicken or pig? (American Pharmacists Association )
Probiotics linked to lower risk of diarrhea from antibiotics (Medical News Today)
Ketamine may offer rapid relief from OCD symptoms (Medscape)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


New P3 MTM pilot project in Maryland expands services to state employees
American Pharmacists Association
Five thousand Maryland state employees will be able to receive medication therapy management services provided by specially trained pharmacists through a new 14-month pilot project of the Maryland P3 Program. Until now, the program has been available primarily to patients at private self-insured companies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pediatric poisonings increase along with adult prescriptions
Pharmacy Times
More children are being exposed to prescription drugs unintentionally due to an increase in the number of drugs prescribed to adults, according to results of a study published in the July issue of Pediatrics. Although public interventions regarding safe medicine storage have reduced the number of overall deaths caused by medication poisonings in children, the number of children visiting emergency rooms as a result of medication ingestion is increasing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Genetic variations impact warfarin doses for African-Americans
Medical News Today
A common genetic variation that can impact the therapeutic dose of the blood-thinning drug warfarin among African-Americans has been found, according to a new report in The Lancet. The finding revealed that people of African ancestry who have the rs12777823 variant require a notably lower dose of warfarin to achieve all the advantages, compared to those without this single-nucleotide polymorphism.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


DDW 2013: PH monitoring could cut down PPI use
Pharmacy Practice News
Almost 30 percent of patients thought to have gastroesophageal reflux disease may be receiving long-term proton pump inhibitors unnecessarily, according to a new study presented at the 2013 Digestive Disease Week meeting. Conducting a pH monitoring study immediately following an initial eight-week trial of PPI treatment could identify many patients who do not need treatment with PPIs and could save thousands of dollars in unnecessary healthcare spending, researchers reported.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
FDA panel: Rosiglitazone restrictions should be eased
Medscape
The diabetes drug rosiglitazone should stay on the market, and the current restrictions on its prescribing should be eased but not lifted entirely, according to the majority vote of a joint advisory panel to the FDA.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Tylenol can ease anxiety over fear of dying
Medical News Today
An over-the-counter pain reliever can also be used to deal with existential worry — anxiety that comes from thinking about death — according to new research from the University of British Columbia.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Opportunities and threats: Technology a double-edge sword for pharmacists
American Pharmacists Association
Life is about risk and rewards, balancing the positive with the negative and taking the good with the bad. Advances in healthcare technology free up pharmacists' time by automating certain tasks so they can dedicate more time to patients.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


Avoid high-dose steroids in elderly with COPD and diabetes
Medscape
In a study of elderly Australians with chronic obstructive pulmonary disease and newly diagnosed diabetes, those who received high-dose corticosteroids had an increased risk of being hospitalized for a diabetes-related complication within a year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Impact of temperature exposure on stability of drugs in a real-world out-of-hospital setting
Annals of Emergency Medicine
The aim of this study is to determine the content of five important emergency medical services drugs after being stored at the recommended refrigerated temperature, room temperature or in an emergency physician transport vehicle operating under real-world working conditions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Short-term sulfonylurea use appears safe for ACS patients
Pharmacy Times
Diabetes and coronary disease are common comorbidities, but the clinical community continues to debate the best management strategy for patients with both conditions. Diabetes is associated with an increased risk of death or heart failure within 30 days of an acute coronary syndrome event. Several observational studies have suggested that diabetes patients treated with sulfonylureas may be at elevated risk of cardiovascular events. The proposed mechanism is the adenosine triphosphate-sensitive potassium channel.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA panel: Rosiglitazone restrictions should be eased
Medscape
The diabetes drug rosiglitazone should stay on the market, and the current restrictions on its prescribing should be eased but not lifted entirely, according to the majority vote of a joint advisory panel to the FDA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 11, 2013
June 4, 2013
May 29, 2013
May 21, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063